IP Library Granted Patent US 7,285,517
Granted Patent B2
US 7,285,517 · App. 10/389,871 · Granted Oct 23, 2007

Warming and nonirritating lubricant compositions and method of comparing irritation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,285,517
App. No.
10/389,871
Granted
Oct 23, 2007
Kind
B2
Abstract

This invention relates to substantially anhydrous warming, non-toxic and nonirritating lubricating compositions containing polyhydric alcohols, a gelling agent and alternatively a pH adjusting agent for treating fungal and bacterial infections. The invention also relates to methods of using such compositions for warming, lubrication, administration of active ingredients and for preventing or treating dysmenorrhea.

Claims (10)

1. Anhydrous antifungal gel compositions comprising at least one polyhydric alcohol, a gelling agent, lactic acid and an antifungal azole compound selected from the group consisting of miconazole, econazole, terconazole, saperconazole, itraconazole, butaconazole, clotrimazole, tioconazole, fluconazole and ketoconazole, vericonazole, fenticonazole, sertaconazole, posaconazole, bifonazole, oxiconazole, sulconazole, elubiol, vorconazole, isoconazole, flutrimazole, tioconazole and their pharmaceutically acceptable salts wherein the gel contains less than 20% water.

2. Anhydrous antifungal gel compositions comprising at least one polyhydric alcohol, a gelling agent, lactic acid and an antifungal azole compound selected from the group consisting of miconazole, econazole, terconazole, saperconazole, itraconazole, butaconazole, clotrimazole, tioconazole, fluconazole and ketoconazole, vericonazole, fenticonazole, sertaconazole, posaconazole, bifonazole, oxiconazole, sulconazole, elubiol, vorconazole, isoconazole, flutrimazole, tioconazole and their pharmaceutically acceptable salts wherein the gel contains less than 5% water.

3. A method of treating vulvovaginal candidiasis comprising administering to a patient in need thereof a composition according to claim 1 .

4. A method of treating vulvovaginal candidiasis comprising administering to a patient in need thereof a composition according to claim 2 .

5. A method of treating a patient with both nail fungal and bacteria infections comprising administering to said patient a composition according to claim 1 .

6. A method of treating a patient with both nail fungal and bacteria infections comprising administering to said patient a composition according to claim 2 .

7. A method of treating bacterial vaginosis comprising administering to a patient in need thereof a composition according to claim 1 .

8. A method of treating a patient with both vulvovaginal candidiasis and bacterial vaginosis comprising administering to said patient a composition according to claim 1 .

9. A method of treating bacterial vaginosis comprising administering to a patient in need thereof a composition according to claim 2 .

10. A method of treating a patient with both vulvovaginal candidiasis and bacterial vaginosis comprising administering to said patient a composition according to claim 2 .

Assignments (3)
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →